User:Shawndouglas/sandbox/sublevel32
1. Overview of COVID-19 and its challenges
1.1 COVID-19: The terminology
A pneumonia-like outbreak sprouted in Wuhan, located in the Hubei province of China, in early December 2019. The WHO was notified by the end of the month that the cause could be a novel threat to the larger populace.[1] By the end of January, the WHO had decided to declare the growing viral threat a Public Health Emergency of International Concern (PHEIC), an act which includes with it a need "to implement a comprehensive risk communication strategy."[2] As the disease progressed beyond its Chinese origins, public confusion slowly grew regarding the terminology surrounding the disease. Leaders at the World Health Organization (WHO) and the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses came to different naming conclusions, differing in their naming conventions and adding to the confusion.[3][4] In the end, "COVID-19" has ended up as the common disease name, caused by the SARS-CoV-2 virus, which is a member of the coronavirus family. Today, however, some still refer to the disease simply as "coronavirus," which is in errror.
This isn't the first time a disease has had a different name from its associated virus. One should look back to 1982, when the U.S. Centers for Disease Control and Prevention (CDC) gave the name "acquired immune deficiency syndrome" or "AIDS" to the disease associated with the human immunodeficiency virus (HIV) (a member of the retrovirus family).[5] It took time for the layman to get used to the terminology, and even then some still ended up mistakenly refering to the disease as "HIV."
1.2 COVID-19: History and impact (so far)
Check various sources here: https://en.wikipedia.org/wiki/Coronavirus_disease_2019
1.3 Challenges of managing the disease in the human population
- median incubation period : https://www.sciencedaily.com/releases/2020/03/200317175438.htm
- asymptomatic and presymptomatic virus shedding : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074995/ and https://www.infectioncontroltoday.com/covid-19/asymptomatic-carriers-covid-19-make-it-tough-target
- high viral loads and cardiac issues : http://www.onlinejacc.org/content/early/2020/03/18/j.jacc.2020.03.031 and https://jamanetwork.com/journals/jamacardiology/fullarticle/2763846
References
- ↑ Hui, D.S.; Azhar, E.I.; Madani, T.A. et al. (2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China". International Journal of Infectious Diseases 91: 264–66. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.
- ↑ World Health Organization (30 January 2020). "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". World Health Organization. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Retrieved 31 March 2020.
- ↑ Enserink, M. (12 February 2020). "Update: ‘A bit chaotic.’ Christening of new coronavirus and its disease name create confusion". Science. https://www.sciencemag.org/news/2020/02/bit-chaotic-christening-new-coronavirus-and-its-disease-name-create-confusion. Retrieved 30 March 2020.
- ↑ Jiang, S.; Shi, Z.; Shu, Y. et al. (2020). "A distinct name is needed for the new coronavirus". The Lancet 395 (10228): 949. doi:10.1016/S0140-6736(20)30419-0. PMID 32087125.
- ↑ Oppenheimer, G.M. (1992). "Chapter 2: Causes, Cases, and Cohorts: The Role of Epidemiology in the Historical Construction of AIDS". In Fee, E.; Fox, D.M.. AIDS: The Making of a Chronic Disease. University of California Press. pp. 49–83. ISBN 0520077784. https://books.google.com/books?id=CmME6xfdEFAC&pg=PA49. Retrieved 31 March 2020.
